Matinas BioPharma Hldgs Q4 EPS $(0.26) Up From $(1.68) YoY

Benzinga Newsdesk www.benzinga.com Negative 60.7%

Neg 60.7% Neu 0% Pos 0%

Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.26) per share. This is a 84.52 percent increase over losses of $(1.68) per share from the same period last year.